首页> 外文OA文献 >Trends in lipid profiles and descriptive characteristics of U.S. adults with and without diabetes and cholesterol-lowering medication use—National Health and Nutrition Examination Survey, 2003–2012, United States
【2h】

Trends in lipid profiles and descriptive characteristics of U.S. adults with and without diabetes and cholesterol-lowering medication use—National Health and Nutrition Examination Survey, 2003–2012, United States

机译:脂质谱的趋势及美国成人的描述性特征,患有糖尿病和胆固醇降低药物用途 - 国家健康和营养考试调查,2003 - 2012年,美国

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

With a cholesterol-lowering focus for diabetic adults and in the age of polypharmacy, it is important to understand how lipid profile levels differ among those with and without diabetes.Investigate the means, differences, and trends in lipid profile measures [TC, total cholesterol; LDL-c, low-density lipoprotein; HDL-c, high-density lipoprotein; and TG, triglycerides] among US adults by diabetes status and cholesterol-lowering medication.Population number and proportion of adults aged ≥21 years with diabetes and taking cholesterol-lowering medication were estimated using data on 10,384 participants from NHANES 2003-2012. Age-standardized means, trends, and differences in lipid profile measures were estimated by diabetes status and cholesterol medication use. For trends and differences, linear regression analysis were used adjusted for age, gender, and race/ethnicity.Among diabetic adults, 52% were taking cholesterol-lowering medication compared to the 14% taking cholesterol-lowering medication without diabetes. Although diabetic adults had significantly lower TC and LDL-c levels than non-diabetic adults [% difference (95% confidence interval): TC = -5.2% (-6.8 --3.5), LDL-c = -8.0% (-10.4 --5.5)], the percent difference was greater among adults taking cholesterol medication [TC = -8.0% (-10.3 --5.7); LDL-c = -13.7% (-17.1 --10.2)] than adults not taking cholesterol medication [TC = -3.5% (-5.2 --1.6); LDL-c = -4.3% (-7.1 --1.5)] (interaction p-value: TC = <0.001; LDL-c = <0.001). From 2003-2012, mean TC and HDL-c significantly decreased among diabetic adults taking cholesterol medication [% difference per survey cycle (p-value for linear trend): TC = -2.3% (0.003) and HDL-c = -2.3% (0.033)]. Mean TC, HDL-c, and LDL-c levels did not significantly change from 2003 to 2012 in non-diabetic adults taking cholesterol medication or for adults not taking cholesterol medications.Diabetic adults were more likely to have lower lipid levels, except for triglyceride levels, than non-diabetic adults with profound differences when considering cholesterol medication use, possibly due to the positive effects from clinical diabetes management.
机译:随着糖尿病成年人的胆固醇的重点,在多酚省期的时代,了解脂质型材水平如何在有糖尿病和没有糖尿病的情况下差异。对脂质剖面测量的手段,差异和趋势进行异化,差异措施[TC,总胆固醇; LDL-C,低密度脂蛋白; HDL-C,高密度脂蛋白;糖尿病状态和降低胆固醇药物的美国成年人中的甘油三酯]和胆固醇的药物。使用来自NHANES 2003-2012的10,384名参与者的数据估计≥21岁,≥21岁的成年人的数量和比例。通过糖尿病状态和胆固醇药物使用估算脂质剖面措施的年龄标准化手段,趋势和差异。对于趋势和差异,针对年龄,性别和种族/种族进行了线性回归分析。糖尿病成人,52%的人服用胆固醇降低药物,而14%以胆固醇降低的药物没有糖尿病。虽然糖尿病患者的TC和LDL-C水平明显低于非糖尿病成分[%差异(95%置信区间):TC = -5.2%(-6.8-3.5),LDL-C = -8.0%(-10.4 - 5.5)],成年人中含胆固醇药物的百分比差异较大[Tc = -8.0%(-10.3 - 5.7); LDL-C = -13.7%(-17.1-10.2)]比未服用胆固醇药物的成人[Tc = -3.5%(-5.2-1.6); LDL-C = -4.3%(-7.1-1.5)](相互作用P值:TC = <0.001; LDL-C = <0.001)。从2003 - 2012年,糖尿病成人的平均TC和HDL-C取得胆固醇药物的糖尿病成人在每次调查循环差异(线性趋势的p值)中显着降低:Tc = -2.3%(0.003)和HDL-C = -2.3% (0.033)]。平均TC,HDL-C和LDL-C水平从2003年到2012年在非糖尿病成年人中没有显着变化,所述非糖尿病成人服用胆固醇药物或未服用胆固醇药物的成年人。糖尿病成年人更有可能具有较低的脂质水平,除了甘油三酯。在考虑胆固醇药物用药时,水平而不是非糖尿病成年人,可能是由于临床糖尿病管理的积极影响。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号